Park City, UT · Founded 2025 · Privately Held (backing)
Provider of living cellular therapy services intended to treat enzyme deficiency disorders through a repeat-infusion model. Glafabra Therapeutics is based in Park City, UT and was founded in 2025. Its last known valuation is $65 million. It has raised $200,000.
Last price · $/share
—
Implied valuation
$65.0M
Total raised
$200K
Last round
—
Cap table — not yet on record
Glafabra Therapeutics's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Glafabra Therapeutics with a free account
·Watch Glafabra Therapeutics: the Monday email on marks, rounds and moves
